Skip to content
10-K/A

Annual Report

Bio Green Med Solution, Inc. BGMS BGMSP

0001493152-25-025179

← back to feed
Filed
Nov 26, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding restated FY 2024 · Mar 27, 2025 863.9K sh
Shares Diluted restated FY 2024 · Dec 31, 2024 22.31M sh
Shares Diluted restated FY 2024 · Dec 31, 2023 3.55M sh
Operating Cash Flow FY 2024 · Dec 31, 2024 −$7.99M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$16.11M
Cash And Equivalents FY 2024 · Dec 31, 2024 $3.14M
Cash And Equivalents FY 2024 · Dec 31, 2023 $3.38M
Stockholders Equity FY 2024 · Dec 31, 2024 −$2.17M
Stockholders Equity FY 2024 · Dec 31, 2023 $607K
Stockholders Equity restated FY 2024 · Dec 31, 2022 $15.94M
Current Liabilities FY 2024 · Dec 31, 2024 $6.27M
Current Liabilities FY 2024 · Dec 31, 2023 $8.16M
Total Liabilities FY 2024 · Dec 31, 2024 $6.27M
Total Liabilities FY 2024 · Dec 31, 2023 $8.2M
Current Assets FY 2024 · Dec 31, 2024 $3.67M
Current Assets FY 2024 · Dec 31, 2023 $7.44M
Total Assets FY 2024 · Dec 31, 2024 $4.09M
Total Assets FY 2024 · Dec 31, 2023 $8.81M
Eps Diluted restated FY 2024 · Dec 31, 2024 −$504.30
Eps Diluted restated FY 2024 · Dec 31, 2023 −$6,419.18
Eps Basic restated FY 2024 · Dec 31, 2024 −$504.30
Eps Basic restated FY 2024 · Dec 31, 2023 −$6,419.18
Rd Expense FY 2024 · Dec 31, 2024 $6.66M
Rd Expense FY 2024 · Dec 31, 2023 $19.16M
Net Income FY 2024 · Dec 31, 2024 −$11.21M
Net Income FY 2024 · Dec 31, 2023 −$22.56M
Operating Income FY 2024 · Dec 31, 2024 −$12M
Operating Income FY 2024 · Dec 31, 2023 −$25.45M
Capex FY 2024 · Dec 31, 2023 $6K